-transparent.png){kind=logo}
Corticotropin releasing factor (CRF) is a 41-residue peptide, capable of stimulating the secretion of corticotropin (ACTH)-like and beta-endorphin-like immunoreactivity from the adenohypophysis. Low doses of CRF (0.0015-0.15 nM) given intracerebroventricularly (i.c.v.) produced changes in electrographic activity suggestive of increased arousal. Higher doses of CRF (1.5-3.75 nM) induced, over a period of 3-7 h, electrographic and behavioral signs of seizure activity indistinguishable from those which occur following electrical 'kindling' of the amygdala.
Related Publications
C L Ehlers, and
S J Henriksen, and
M Wang, and
J Rivier, and
W Vale, and
F E Bloom
May 1982,
Nature,
C L Ehlers, and
S J Henriksen, and
M Wang, and
J Rivier, and
W Vale, and
F E Bloom
December 1996,
Brain research,
C L Ehlers, and
S J Henriksen, and
M Wang, and
J Rivier, and
W Vale, and
F E Bloom
September 1987,
Brain research,
C L Ehlers, and
S J Henriksen, and
M Wang, and
J Rivier, and
W Vale, and
F E Bloom
December 2015,
Journal of neurophysiology,
C L Ehlers, and
S J Henriksen, and
M Wang, and
J Rivier, and
W Vale, and
F E Bloom
October 1992,
Brain research. Molecular brain research,
C L Ehlers, and
S J Henriksen, and
M Wang, and
J Rivier, and
W Vale, and
F E Bloom
January 1998,
Brain research,
C L Ehlers, and
S J Henriksen, and
M Wang, and
J Rivier, and
W Vale, and
F E Bloom
July 1991,
Brain research,
C L Ehlers, and
S J Henriksen, and
M Wang, and
J Rivier, and
W Vale, and
F E Bloom
December 2003,
Brain research,
C L Ehlers, and
S J Henriksen, and
M Wang, and
J Rivier, and
W Vale, and
F E Bloom
October 1985,
Endocrinologia japonica,
C L Ehlers, and
S J Henriksen, and
M Wang, and
J Rivier, and
W Vale, and
F E Bloom
May 1990,
Brain research,
